tributyl phosphate has been researched along with Virus Diseases in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 7 (58.33) | 18.2507 |
2000's | 4 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lloyd, D; Marshall, PJ; Roberts, PL | 1 |
Dunkerley, C; Roberts, PL | 1 |
Burnouf, T; El-Ekiaby, M; Gorgy, G; Goubran, HA; Radosevich, M; Sayed, MA | 2 |
Eriksson, B; Jernberg, M; Westman, L | 1 |
Gürtler, L | 1 |
Biescas, H; Darling, A; Fernández, J; Gensana, M; Jorquera, JI; Massot, M; Ristol, P; Vericat, F | 1 |
Rice, KM; Savidge, GF; Smith, MP | 1 |
Dodd, RY; Dzik, WH; Klein, HG; Luban, NL; Ness, PM; Pisciotto, P; Schiff, PD; Snyder, EL | 1 |
Barford, JP; Harbour, C; MacLeod, AJ; Spencer, J; Woodhouse, G | 1 |
Horowitz, B | 1 |
Gomperts, ED | 1 |
3 review(s) available for tributyl phosphate and Virus Diseases
Article | Year |
---|---|
Virus validation of plasma-derived products produced by Pharmacia, with particular reference to immunoglobulins.
Topics: Animals; Antiviral Agents; Consumer Product Safety; Heating; Humans; Immunoglobulins; Organophosphates; Plasma; Polysorbates; Research Design; Virus Diseases | 1994 |
[Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
Topics: Acquired Immunodeficiency Syndrome; Blood Transfusion; Blood-Borne Pathogens; Detergents; Hepatitis B; Hepatitis C; Humans; Organophosphates; Risk Factors; Virus Diseases | 1994 |
Inactivation of viruses found with plasma proteins.
Topics: Blood; Blood Proteins; Detergents; Freeze Drying; Hepatitis, Viral, Human; HIV Infections; Hot Temperature; Humans; Organophosphates; Propiolactone; Risk; Safety; Transfusion Reaction; Ultraviolet Rays; Virus Diseases; Viruses | 1991 |
9 other study(ies) available for tributyl phosphate and Virus Diseases
Article | Year |
---|---|
Virus inactivation in a factor VIII/VWF concentrate treated using a solvent/detergent procedure based on polysorbate 20.
Topics: Animals; Cell Survival; Cells, Cultured; Chemical Precipitation; Chlorocebus aethiops; Detergents; Drug Combinations; Drug Contamination; Factor VIII; Organophosphates; Polysorbates; Solvents; Temperature; Vero Cells; Virus Diseases; Virus Inactivation; von Willebrand Factor | 2009 |
Effect of manufacturing process parameters on virus inactivation by solvent-detergent treatment in a high-purity factor IX concentrate.
Topics: Detergents; Drug Industry; Factor IX; Humans; Kinetics; Organophosphates; Polysorbates; Solvents; Sterilization; Temperature; Virus Diseases; Viruses | 2003 |
A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system.
Topics: Blood Banks; Blood Component Transfusion; Blood Preservation; Cryopreservation; Detergents; Developing Countries; Factor VIII; Fibrinogen; Hemophilia A; Humans; Octoxynol; Organophosphates; Virus Diseases; Virus Inactivation | 2006 |
A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
Topics: Blood Banks; Blood Preservation; Blood Proteins; Blood Transfusion; Humans; Octoxynol; Organophosphates; Virus Diseases; Virus Inactivation | 2006 |
[Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
Topics: Blood; Chromatography, Affinity; Detergents; Evaluation Studies as Topic; Factor VIII; Hemophilia A; Hepatitis Viruses; HIV; Hot Temperature; Humans; Organophosphates; Parvovirus B19, Human; Polysorbates; Safety; Solvents; Virus Diseases | 1996 |
Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment.
Topics: Adolescent; Adult; Aged; Blood; Child; Detergents; Drug Evaluation; Factor VIII; Freeze Drying; Hemophilia A; Hepatovirus; Hot Temperature; Humans; Isoantibodies; Middle Aged; Organophosphates; Parvovirus, Canine; Polysorbates; Safety; Solvents; Virus Diseases | 1997 |
Current status of solvent/detergent-treated frozen plasma.
Topics: Blood Banks; Blood Preservation; Detergents; Drug Approval; Humans; Octoxynol; Organophosphates; Plasma; Risk Assessment; Solvents; Transfusion Reaction; United States; United States Food and Drug Administration; Virus Diseases; Viruses | 1998 |
Viral contamination of therapeutic proteins: a challenge for downstream processing.
Topics: Antibodies, Monoclonal; Blood Proteins; Deltaretrovirus; Drug Contamination; Freeze Drying; HIV; Hot Temperature; Humans; Organophosphates; Propiolactone; Proteins; Virus Diseases; Viruses | 1991 |
Procedures for the inactivation of viruses in clotting factor concentrates.
Topics: Animals; Blood Coagulation Factors; Deltaretrovirus; Detergents; Hemostasis; Hepatitis Viruses; Hot Temperature; Humans; In Vitro Techniques; Organophosphates; Pan troglodytes; Ultraviolet Rays; Virus Diseases | 1986 |